JANUARY
2001
WEEK ENDING JANUARY 5
PRODUCT Collyrium Eye Wash, (Boric
Acid) in 4-fluid ounce (118 mL) bottles, OTC aqueous ophthalmic solution
indicated for cleansing the eye, under the Wyeth and Bausch & Lomb
labels.
CODE Wyeth Laboratories, Inc. labeled product bearing lot
numbers: 3981543 EXP 6/01; 3982156 EXP
6/01; 3982217 EXP 6/01; Bausch & Lomb labeled product bearing lot numbers:
3982224 EXP 7/01; 3982225 EXP 8/01; 3982226 EXP 9/01; 3991526 EXP 1/02; 3991172
EXP 1/02; 3991269 EXP 4/02; 3990414 EXP 7/02.
MANUFACTURER Wyeth-Ayerts Pharmaceuticals, Inc., Rouses
Point, New York (contract manufacturer).
RECALLED BY Bausch & Lomb, Inc., Rochester, New York
DISTRIBUTION Nationwide.
QUANTITY Volume of product in commerce:
Lot
3981543: 26,256 bottles
Lot
3982156: 79,032 bottles
Lot
3982217: 78,636 bottles
Lot
3982224: 78,684 bottles
Lot
3982225: 78,612 bottles
Lot
3982226: 78,888 bottles
Lot
3991526: 78,828 bottles
Lot
3991172: 77,484 bottles
Lot
3991269: 78,348 bottles
Lot
3990414: 49,656 bottles.
REASON Phenol contamination (labeling component migration
across the container wall).
PRODUCT Premarin Conjugated
a) Premarin (r) tablets (conjugated estrogens tablets),0.625 mg, 100 & 1,000 count bottles;
b)
Premarin (r) tablets (conjugated estrogens tablets), 1.25mg, 100 & 1,000
count bottles;
c)
Premarin (r) tablets (conjugated estrogens tablets, 2.5mg, 100 count
bottles.
CODE STRENGTH: 0.625 mg/100 count bottles:
a)
Lot #9990086 Exp. 9/02, Lot #9990086 Exp. 12/03, Lot #999029U Exp. 11/03, Lot #9990585W Exp. 11/03,
STRENGTH:
0.625 mg/1,000 count bottles: Lot #9990086 Exp.
9/02, Lot #9980299 Exp. 11/02;
STRENGTH
1.25 mg/100 count bottles/NDC #0046-0866-81:
b)
Lot #9980874 Exp. 2/03; STRENGTH: 1.25
mg/1,000 count bottles: Lot #9980874 Exp. 2/03; STRENGTH: 2.5 mg/100 count
bottles046-0865-81:
c)
Lot #9990175 Exp. 10/03.
MANUFACTURER Wyeth-Pharmaceuticals Co., Gauyama, Puerto
Rico.
RECALLED BY National Pharmpak Svcs, Incorporated, Zanesville,
Ohio
DISTRIBUTION Nationwide and New Mexico, Puerto Rico.
QUANTITY 108,394 bottles were distributed.
REASON Manufacturer failed to meet USP dissolution
specifications for Conjugated Estrogen.